For: | Zhu Q, Gao BQ, Zhang JF, Shi LP, Zhang GQ. Successful treatment of lichen amyloidosis coexisting with atopic dermatitis by dupilumab: Four case reports. World J Clin Cases 2023; 11(11): 2549-2558 [PMID: 37123319 DOI: 10.12998/wjcc.v11.i11.2549] |
---|---|
URL: | https://www.wjgnet.com/2307-8960/full/v11/i11/2549.htm |
Number | Citing Articles |
1 |
Benedetta Tirone, Gerardo Cazzato, Francesca Ambrogio, Caterina Foti, Marco Bellino. Lichen Amyloidosis in an Atopic Patient Treated with Dupilumab: A New Therapeutic Option. Diseases 2024; 12(5): 94 doi: 10.3390/diseases12050094
|
2 |
Feiying Guo, Huajie Zhong, Yuan Wu, Xue Xu, Jiarong Tan, Qiang Zhou, Shunli Tang. Dupilumab for treatment of primary cutaneous amyloidosis in adults: two case reports and literature review. Frontiers in Medicine 2025; 12 doi: 10.3389/fmed.2025.1485079
|
3 |
Alexandru-Florin Florescu, Oana-Claudia Sima, Claudiu Nistor, Mihai-Lucian Ciobica, Mihai Costachescu, Mihaela Stanciu, Denisa Tanasescu, Florina Ligia Popa, Mara Carsote. Endocrine Perspective of Cutaneous Lichen Amyloidosis: RET-C634 Pathogenic Variant in Multiple Endocrine Neoplasia Type 2. Clinics and Practice 2024; 14(6): 2284 doi: 10.3390/clinpract14060179
|
4 |
Yizhen Zhang, Dawei Huang, Yunlu Gao. Case report: Abrocitinib: a potential therapeutic option for lichen amyloidosis associated with atopic dermatitis. Frontiers in Immunology 2024; 15 doi: 10.3389/fimmu.2024.1477664
|
5 |
Qin-Xiao Wang, Qian Ye, Kai-Yi Zhou, Si-Yu Luo, Sheng Fang. Systematic review and meta-analysis of treatments and outcomes in primary localized cutaneous amyloidosis. Clinical and Experimental Dermatology 2025; doi: 10.1093/ced/llaf081
|
6 |
M. Amiot, I. Moulonguet. Amylose papuleuse (« lichen amyloïde »). Annales de Dermatologie et de Vénéréologie - FMC 2024; 4(7): 471 doi: 10.1016/j.fander.2023.10.014
|